Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
X4 Pharmaceuticals, Inc. (XFOR) had Free Cash Flow per Share of $-0.32 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$8.81M |
|
$-16.16M |
|
$1.62M |
|
$7.19M |
|
$25.20M |
|
$-16.39M |
|
$0.24M |
|
$-16.16M |
|
$-16.16M |
|
$-16.16M |
|
$-16.16M |
|
$-16.16M |
|
$-16.16M |
|
$-16.39M |
|
$-15.39M |
|
126.34M |
|
126.34M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$218.85M |
|
$0.11M |
|
$34.21M |
|
$253.06M |
|
$19.37M |
|
$76.76M |
|
$78.24M |
|
$97.61M |
|
$155.45M |
|
$125.00M |
|
$155.45M |
|
96.11M |
|
| Cash Flow Statement Financials | |
$-40.39M |
|
$18.25M |
|
$0.08M |
|
$217.85M |
|
$195.77M |
|
$-22.08M |
|
$5.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.30 |
|
-- |
|
-- |
|
0.33 |
|
0.49 |
|
81.64% |
|
-186.13% |
|
-186.13% |
|
-- |
|
-183.45% |
|
-183.48% |
|
$-40.39M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.29 |
|
4.30 |
|
20.92 |
|
-10.39% |
|
-12.93% |
|
-6.38% |
|
-6.96% |
|
$1.62 |
|
|
Free Cash Flow per Share |
$-0.32 |
$-0.32 |
|